George A. Eldridge, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 17,355 shares at $30.04 ($479K) on 2022-12-12, disclosed to the SEC on 2022-12-13.
Open-market sale of $479k AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.23 | 3,386 | $82K | 17.1% |
| 2 | $24.23 | 3,386 | $82K | 17.1% |
| 3 | $25.23 | 583 | $15K | 3.1% |
| 4 | $30.04 | 10,000 | $300K | 62.7% |
| Total | $27.61 avg | 17,355 | $479K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-03 | $780K | — | Filing → |
| AVTE | SELL | 2024-03-14 | $204K | — | Filing → |
| AVTE | SELL | 2024-03-11 | $736K | — | Filing → |